Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 20/20 | 1.00 |
| ▸ | CTSL | P07711 | 10/20 | 1.00 |
| ▸ | CTSS | P25774 | 10/20 | 1.00 |
| ▸ | CTSV | O60911 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15241306 | 1.00 | CTSK (1.00) | CTSKCTSLCTSSCTSV | |
| SCHEMBL15241298 | 1.00 | CTSK (1.00) | CTSKCTSLCTSSCTSV | |
| SCHEMBL11925968 | 1.00 | CTSK (1.00) | CTSKCTSLCTSSCTSV | |
| SCHEMBL1169168 | 0.89 | CTSK (0.81) | CTSKCTSLCTSSCTSV | |
| SCHEMBL12865568 | 0.89 | CTSK (0.82) | CTSKCTSLCTSS | |
| SCHEMBL21137232 | 0.88 | CTSK (1.00) | CTSKCTSLCTSS | |
| SCHEMBL16485886 | 0.88 | CTSK (1.00) | CTSKCTSLCTSS | |
| SCHEMBL22266813 | 0.88 | CTSK (0.90) | CTSKCTSLCTSS | |
| SCHEMBL11925963 | 0.88 | CTSK (1.00) | CTSKCTSLCTSS | |
| SCHEMBL1146979 | 0.88 | CTSK (1.00) | CTSKCTSLCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11312693-B2 | Protease inhibitors | MEDIVIR AB (SE) | 2022-04-26 | — | — | US | disclosed |
| US-20210017140-A1 | PROTEASE INHIBITORS | MEDIVIR AB (SE) | 2021-01-21 | — | — | US | disclosed |
| US-10329266-B2 | Protease inhibitors | MEDIVIR AB (SE) | 2019-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11312693-B2 | Protease inhibitors | CTSK, CTSF, CTSS | CTSK 1/4885CTSL 8/4885CTSS 3/4885 |
| US-10329266-B2 | Protease inhibitors | CTSK, CTSF, CTSS | CTSK 1/4885CTSL 8/4885CTSS 3/4885 |
| US-20210017140-A1 | PROTEASE INHIBITORS | CTSK, CTSF, CTSS | CTSK 1/4885CTSL 8/4885CTSS 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.